Date: 2012-11-05
Type of information:
Compound: expansion of CTX cells, production of a GMP Drug Substance batch and associated testing
Company: Angel Biotechnology (UK) Reneuron (UK)
Therapeutic area: undisclosed
Type agreement: manufacturing
production
Action mechanism:
Disease: undisclosed
Details: Angel Biotechnology, the biopharmaceutical contract manufacturer, has announced the signing of a new contract with ReNeuron Group plc. This contract relates to the expansion of CTX cells, the production of a GMP Drug Substance batch and associated testing. The contract is scheduled for completion in the current financial year.
Financial terms:
Latest news:
